| Name: |
|
| Other Names: |
|
|
Classification:
|
- Class III Antidysrhythmic
|
|
Mechanism of Action:
|
- Prolongs the cardiac action potential and refractory period
- Inhibits alpha and beta-adrenergic stimulation resulting in relaxation of vascular smooth muscle and decreases peripheral vascular resistance
- Class I – blocks Na channels, Class II – Inhibits sympathetic stimulation, Class III – blocks K channels, Class IV- blocks Ca channels (weakly)
- Increases the VF threshold
- Negative chronotropic effects
- Slows conduction through the AV node
- Increases PR & QT intervals
|
|
Indications:
|
- Refractory VF/pulseless VT
- Polymorphic VT and wide complex tachycardia of unknown origin
- Control of hemodynamically stable VT
- Runs of VT post cardiac arrest
|
|
Contraindications:
|
- Hypersensitivity or known iodine hypersensitivity (iodine makes up a large part of the amiodarone molecule)
- Bradycardia
- 2nd & 3rd Degree heart block
- Sinus node dysfunction
|
|
Precautions:
|
- Bradycardia
- Monitor BP may produce vasodilation/ hypotension
- When given with digitalis preparations, may cause digitalis toxicity
- Pulmonary disease
- Hepatic or renal disease
- May prolong QT interval
- Hypokalemia/hypomagnesaemia
|
|
Adverse Effects:
|
- Hypotension
- Headache
- Dizziness
- Bradycardia
- AV conduction abnormalities
- Flushing and abnormal salivation
|
|
Dose:
|
|
|
Adult:
|
- VF/VT Cardiac Arrest: 300 mg IV/IO push then 150 mg IV/IO push after 4 minutes if required.
- VT with a pulse/runs of VT post cardiac arrest: 150 mg IV/IO diluted in 100 mL normal saline and administered over 10 minutes (15 mg/min); repeated q 10 minutes as required.
|
|
Pediatric:
|
- VF/VT Cardiac Arrest: 5 mg/kg IV/IO push (max single dose 300 mg); repeated q 4 minutes as required (maximum total dose (15 mg/kg).
- VT with a pulse/runs of VT post cardiac arrest (with MCCP approval): 5 mg/kg IV diluted in 100 mL normal saline and administered over 20 minutes (maximum single dose 300 mg); repeated q 10 minutes as required (maximum total dose of 15 mg/kg).
|
| Routes: |
|
| References: |
- Compendium of Pharmaceuticals and Specialties (CPS)
- Pharmacology for the Prehospital Professional 2nd Edition
|
Last modified: Thursday, 13 March 2025, 4:38 PM